Safety and Feasibility of a Low Carbohydrate Diet in Children With Type 1 Diabetes
1 other identifier
interventional
8
1 country
1
Brief Summary
Good glycemic control in individuals with Type 1 diabetes (T1D), has been proven to reduce the risk of diabetes-related complications. Despite technological advances such as the use of insulin delivery devices and continuous glucose monitoring, the average glycemic control in T1D is poor. Though dietary management plays a major role in the overall management of T1D, and it is often classified as the most challenging aspect of treatment, the 2019 Standards of Medical Care in Diabetes for children and adolescents do not clearly address dietary management. As carbohydrate is the macronutrient with the greatest impact on blood glucose, it is reasonable to suggest that carbohydrate reduction will minimize postprandial glucose excursions and improve diabetes control. For this reason, low carbohydrate diets (LCD) have gained popularity, and observational studies report positive glycemic outcomes. However, to date, scientific evidence from randomized trials on the impact of LCD in children with T1D is lacking. Thus, the over-arching goal of this pilot study is to evaluate the feasibility and safety of a low carbohydrate diet in children with T1D, and as an exploratory aim, we will evaluate the efficacy of LCD on glycemic control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2019
CompletedFirst Posted
Study publicly available on registry
January 14, 2020
CompletedStudy Start
First participant enrolled
November 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedMarch 9, 2022
March 1, 2022
1.3 years
December 11, 2019
March 7, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Number of hypoglycemic events
Using a continuous glucose monitor (CGM) and home glucose meter, investigators will calculate the number of hypoglycemic events (glucose values \<70 mg/dL but ≥ 54 mg/dL and those \<54 mg/dL), number of severe hypoglycemia and time spent in hypoglycemia (values \<70 mg/dL but ≥ 54 mg/dL and \<54 mg/dL).
6 month study period
Episodes of diabetes related visits to the hospital, DKA
Investigators will obtain data prospectively from medical records and will estimate the frequency of DKA, diabetes related hospitalizations / emergency department visits.
6 month study period
Dyslipidemia
Investigators will evaluate the changes in LDL levels among the study groups.
6 month study period
Secondary Outcomes (2)
Glycemic control
6 month duration of the study
Glucose variability
6 month study period
Study Arms (2)
Low carb diet intervention group
EXPERIMENTALLow carbohydrate diet defined as 25-35% of total energy intake
Control
NO INTERVENTIONStandard diet defined as 45-65% total energy intake
Interventions
25-35% of carbohydrates from total energy intake
Eligibility Criteria
You may qualify if:
- Patients 5-11 years of age, with history of Type 1 diabetes for longer than 2 years,
- No carbohydrate restrictions at the time of recruitment.
- No medications that could affect appetite
- Regular attendance at the clinic (3-4 times per year),
- Glycated hemoglobin (HbA1c) \<10%.
You may not qualify if:
- Impaired renal or liver function,
- Chronic seizures or global developmental delay,
- Diagnosed with ADHD and/or on ADHD medications
- Use of drugs other than insulin affecting glucose metabolism
- Severe eczema
- Celiac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Washington University School of Medicinelead
- ICTS BJHcollaborator
- Center for Diabetes Translation Researchcollaborator
Study Sites (1)
St Louis Children's Hospital
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2019
First Posted
January 14, 2020
Study Start
November 10, 2020
Primary Completion
February 28, 2022
Study Completion
February 28, 2022
Last Updated
March 9, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share